Article
Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)
Fecha
2017Registro en:
BRAHIM, Lucia Regina et al. Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013). Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 112, n. 12, p. 838-843, Dec. 2017.
0074-0276
10.1590/0074-02760160478
1678-8060
Autor
Brahim, Lucia Regina
Valete-Rosalino, Cláudia Maria
Antônio, Liliane de Fátima
Pimentel, Maria Inês Fernandes
Lyra, Marcelo Rosandiski
Paes, Luiz Eduardo de Carvalho
Costa, Ananda Dutra da
Vieira, Iracema Forni
Dias, Cristina Maria Giordano
Duque, Maria Cristina de Oliveira
Marzochi, Mauro Celio de Almeida
Schubach, Armando de Oliveira